• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine. Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron.

Giuseppe

Emeritus
Vaccine. 2009 Sep 17. [Epub ahead of print]

Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron.

Naskalska A, Szolajska E, Chaperot L, Angel J, Plumas J, Chroboczek J. - Institute of Biochemistry and Biophysics (IBB), Polish Academy of Sciences, ul. Pawinskiego 5a, 02-106 Warsaw, Poland.

We propose a novel influenza vaccine composed of the adenovirus dodecahedron (Dd) as delivery platform carrying an internal influenza matrix protein M1. To attach the antigen to the vector we used WW domains interacting with Dd. Successful internalization of the Dd-M1WW complex was observed using biochemical and cell biology techniques. We show here that the complex of Dd with antigen is a potent activator of human myeloid dendritic cells (MDC), and that it is efficiently presented by MDC to M1-specific CD8+ T lymphocytes. These results show that proposed vaccine model is feasible and that adenovirus dodecahedron is a potent delivery platform for foreign antigens to human cells.

PMID: 19766576 [PubMed - as supplied by publisher]

-
------
 
Back
Top Bottom